Jordan Lake, MD, MSc (Program Coordinator/Faculty Mentor) is Associate Professor in the University of Texas, Houston McGovern Medical School. Her research interests focus on metabolic and inflammatory complications of antiretroviral therapy, as well as the HIV prevention and treatment needs of Latino populations.
Metabolic complications of antiretroviral therapy
HIV and aging
Vitamin D deficiency and HIV infection
HIV, hormone therapy and inflammation in transgender women
Selected Recent Publications:
Lake JE, Tseng CH, Currier JS. The Metabolic Abnormalities, Telmisartan, and HIV Infection Trial. PLoS ONE. 2013; 8(3):e58135.
Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Stramotas SA, Tracy R, Currier JS. Switch to Raltegravir Decreases Soluble CD14 in Virologically Suppressed Overweight Women: The Women, Integrase and Fat Accumulation Trial. HIV Medicine. 2014 Feb 10.
Lake JE, Vo Q, Jacobson LP, Sacktor N, Post WS, Becker J, Palella FJ, Ragin A, Brown TT. Adiponectin and Interleukin-6, But Not Adipose Tissue, Are Associated with Worse Neurocognitive Function in HIV-Infected Men. Antivir Ther. 2015 Mar 26.
Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH and Currier JS. Telmisartan to Reduce Cardiovascular Risk in Older HIV-Infected Adults: A Pilot Study. HIV Clinical Trials. In press.
The priority application deadline is Friday, January 25th, 2019.